Search alternatives:
significant non » significant gap (Expand Search), significant amount (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
significant non » significant gap (Expand Search), significant amount (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
-
1
-
2
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
-
3
Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations.
Published 2025“…Data represent mean values ± standard deviation, n = 3. <b>Legends:</b> ns: non-significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.…”
-
4
-
5
-
6
-
7
-
8
Effects of increasing gravel on initial escape latency in non-injured <i>vs.</i>
Published 2025“…</b> However latency was significantly decrease for the 40 g condition in the injured day 0 animals. **** indicates significant differences across increasing amounts of gravel (p < 0.0001). * indicates a post-hoc test confirming a significant difference between injured and non-injured animals 40 g (p < 0.05).…”
-
9
-
10
Inotodiol decreases clone formation in HCC cells.
Published 2025“…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …”
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
Individual stability values for different gait events under various conditions.
Published 2024Subjects: